- Купить крипто
- Рынки
- Фьючерсы
- Спот
- Копитрейдинг
WE-Launch
US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
Вам также может понравиться
Растущие активы
Последние новости криптовалют
Крипторынок пережил подъем с масштабным всплеском. SUI и PENGU выросли более чем на 20%.
Трамп заявил, что председатель ФРС должен снизить процентные ставки, повторил критику Пауэлла
In the past 24 hours, the entire network liquidated $376 million, with the majority coming from the largest short position
The probability of a 25 basis point interest rate cut by the Federal Reserve in December is currently at 87.2%.
Trump: Объявит нового председателя ФРС в начале следующего года
Служба поддержки：@weikecs
Деловое сотрудничество：@weikecs
Количественная торговля и ММ：[email protected]
VIP-программа：[email protected]
App